External Validation of Dementia Risk Prediction Models: Towards evidence‐based implementation
Externe Validierung von Modellen zur Vorhersage des Demenzrisikos: Hin zu evidenzbasierter Implementierung
Alzheimer's & Dementia · 2025-12 · 21 (S6)
DOI: 10.1002/alz70860_101969 ↗Auf einen Blick
Ein Umbrella-Review mit Metaanalyse bewertete extern validierte Demenz-Risikomodelle. BDSI und GRS-19 zeigten eine angemessene Vorhersage, CAIDE eine schlechte.
Fragestellung
Wie gut ist die Vorhersageleistung extern validierter Demenz-Risikomodelle?
Methode
Umbrella-Review und Metaanalyse auf Basis von drei publizierten systematischen Reviews; aktualisierte Suche im November 2024.
Ergebnisse
39 externe Validierungsstudien. BDSI: gepoolte c-statistic 0,72 (95 %-KI 0,69–0,75; n=13). GRS-19: 0,76 (95 %-KI 0,74–0,79; n=10). CAIDE: 0,60 (95 %-KI 0,55–0,65; n=12).
Einschränkungen
Validierung nur in Hoch- und Ländern mit mittlerem Einkommen; Heterogenität wahrscheinlich durch methodische Unterschiede.
Schlussfolgerung der Autor:innen
Mit weiterer Prüfung unter Alltagsbedingungen könnten Demenz-Risikomodelle mit angemessener externer Validität klinisch eingesetzt werden, um frühe Risikoerkennung und Präventionsplanung zu unterstützen.
Kernaussagen
- BDSI und GRS-19 hatten eine angemessene Vorhersageleistung.
- CAIDE zeigte eine schlechte Vorhersageleistung.
- Validierung erfolgte ausschließlich in Hoch- und mittleren Einkommensländern.
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 23.12.2025. Verfasst von Blossom CM Stephan und 11 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Demenz
Abstract (Originalsprache)
Background
Increasing dementia case numbers globally necessitates accurate and valid prediction tools for early intervention and prevention. Although over 100 different dementia prediction models exist none are endorsed for clinical use. With so many distinct models, it is difficult to make recommendations on which model should be selected for use. External validation – the assessment of model performance in populations distinct from the sample they were developed in – is critical for establishing utility and generalisability. Therefore, we undertook an umbrella review and meta‐analysis to evaluate the predictive performance of externally validated dementia prediction models.
Method
We synthesised results from our three published systematic reviews on dementia risk prediction model development and testing, covering all literature from inception to mid‐2023. We also undertook an updated literature search (November 2024). Included studies were population‐based cohorts that evaluated predictive accuracy (e.g., c‐statistic) for an externally validated dementia prediction model. Meta‐analysis was conducted for models externally validated in ≥10 independent studies.
Result
Out of 39 external validation studies, three models have been independently validated in ≥10 studies including the Brief Dementia Screening Indicator (BDSI), the Cardiovascular Risk Factors, Ageing and Dementia risk score (CAIDE) and the Genetic Risk Score‐19 (GRS‐19). Model validation has been exclusively undertaken in high and middle‐income countries. The meta‐analysis results show that the BDSI (pooled c‐statistic=0.72; 95%CI: 0.69‐0.75; I 2 =0.87; n = 13 external validations) and GRS‐19 (pooled c‐statistic=0.76; 95%CI: 0.74‐0.79; I 2 =0.81; n = 10 external validations), had reasonable predictive accuracy for dementia. In contrast, the CAIDE score showed poor accuracy (pooled c‐statistic=0.60; 95%CI: 0.55‐0.65; I 2 =0.95; n = 12 external validations). Limited transportability and heterogeneity in the results is likely due to methodological differences across studies, for example in sample age distribution and duration of follow‐up.
Conclusion
With further real‐world testing, dementia risk prediction models that demonstrate reasonable external validity could be implemented in clinical settings to support early risk identification and preventative planning. Moving forward, research should evaluate the clinical impact and cost‐effectiveness of dementia risk screening, particularly in diverse populations and low/middle‐income countries, to optimize early detection and prevention efforts.
Zitieren
APA
Stephan, B. C., Brain, J., Buchanan, T., Burley, C. V., Burton, E., Dunne, J., Myers, B., Sabatini, S., Stephan, W., Tang, E. Y. H., Anstey, K. J., & Siervo, M. (2025). External Validation of Dementia Risk Prediction Models: Towards evidence‐based implementation. Alzheimer's & Dementia, 21(S6). https://doi.org/10.1002/alz70860_101969
Vancouver
Stephan BC, Brain J, Buchanan T, Burley CV, Burton E, Dunne J, et al. External Validation of Dementia Risk Prediction Models: Towards evidence‐based implementation. Alzheimer's & Dementia. 2025;21(S6). doi:10.1002/alz70860_101969
BibTeX
@article{Stephan2025,
author = {Stephan, Blossom CM and Brain, Jacob and Buchanan, Tanya and Burley, Claire V and Burton, Elissa and Dunne, Jennifer and Myers, Bronwyn and Sabatini, Serena and Stephan, William and Tang, Eugene Yee Hing and Anstey, Kaarin J. and Siervo, Mario},
title = {External Validation of Dementia Risk Prediction Models: Towards evidence‐based implementation},
journal = {Alzheimer's & Dementia},
year = {2025},
volume = {21},
number = {S6},
doi = {10.1002/alz70860_101969}
}
EUVIMED